Ryuji Matsumoto

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Cross Sectional

Prostate Cancer

Editorial Comment

Top Venues

International journal of urology : official journal of the Japanese Urological Association

IJU case reports

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara, Ryuji Matsumoto, Hideaki Miyake, Nobuaki Matsubara, Hiroji Uemura, Masatoshi Eto, Haruhito Azuma, Wataru Obara, Akito Terai, Satoshi Fukasawa, Shigetaka Suekane
TAS0313 Plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma. Molecular cancer therapeutics (2023)
Yusuke Yamagata, Takashige Abe, Naoya Iwahara, Kohichi Takada, Yasuhiro Hida, Emi Takakuwa, Hiroshi Kikuchi, Ryuji Matsumoto, Takahiro Osawa, Nobuo Shinohara
Metastatic neuroendocrine carcinoma of right adrenal gland successfully treated with laparoscopic adrenalectomy after multimodal therapy. IJU case reports 5 (6) (2022)
Ryuji Matsumoto
Editorial Comment to "A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer". International journal of urology : official journal of the Japanese Urological Association 30 (3) (2022)
Ryuji Matsumoto
Editorial Comment to "A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer". International journal of urology : official journal of the Japanese Urological Association (2022)
Takuma Kato, Akira Yokomizo, Ryuji Matsumoto, Yoichiro Tohi, Jimpei Miyakawa, Koji Mitsuzuka, Hiroshi Sasaki, Junichi Inokuchi, Masafumi Matsumura, Shinichi Sakamoto, Hidefumi Kinoshita, Hiroshi Fukuhara, Naoto Kamiya, Ryu Kimura, Masahiro Nitta, Hiroshi Okuno, Koichiro Akakura, Yoshiyuki Kakehi, Mikio Sugimoto
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study. International journal of urology : official journal of the Japanese Urological Association 29 (11) (2022)
Ryuji Matsumoto
Editorial Comment to "A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer". International journal of urology : official journal of the Japanese Urological Association 30 (3) (2022)
Hiroki Takeda, Ryuji Matsumoto, Emi Takakuwa, Kanta Hori, Takuya Moriguchi, Shuhei Yamada, Hiroshi Kikuchi, Takahiro Osawa, Takashige Abe, Nobuo Shinohara
Favorable response to pembrolizumab in granulocyte colony-stimulating factor-producing upper urinary tract urothelial carcinoma. IJU case reports 5 (2) (2021)
Naoya Iwahara, Takashige Abe, So Nagai, Masanao Yoshino, Hitoshi Saito, Hiromi Okada, Hiroshi Kikuchi, Ryuji Matsumoto, Takahiro Osawa, Nobuo Shinohara
Postoperative thyroid storm after radical nephrectomy for renal cell carcinoma with inferior vena cava tumor thrombus. IJU case reports 4 (5) (2021)